New radiation approach aims to delay pain in Tough-to-Treat prostate cancer
NCT ID NCT06978296
First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 17 times
Summary
This early-phase study tests a precise radiation technique (stereotactic radiotherapy) in 18 men with advanced prostate cancer that has spread to bones or lymph nodes and is no longer responding to standard treatments. The goal is to find the largest total volume of tumors that can be safely treated at once, with the hope of delaying severe pain or complications. The study focuses on safety and tolerability, not on curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
ICO
Saint-Herblain, 44805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.